RECCHIA, FABIO ANASTASIO
 Distribuzione geografica
Continente #
NA - Nord America 22.535
EU - Europa 13.015
AS - Asia 9.140
SA - Sud America 1.536
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 87
OC - Oceania 43
AN - Antartide 1
Totale 46.542
Nazione #
US - Stati Uniti d'America 21.858
SG - Singapore 3.444
GB - Regno Unito 3.413
RU - Federazione Russa 2.671
CN - Cina 2.452
IT - Italia 1.593
UA - Ucraina 1.299
VN - Vietnam 1.250
BR - Brasile 1.240
DK - Danimarca 1.118
DE - Germania 1.104
HK - Hong Kong 811
CA - Canada 511
SE - Svezia 455
FR - Francia 393
BD - Bangladesh 362
FI - Finlandia 308
IE - Irlanda 203
IN - India 179
MX - Messico 115
PL - Polonia 110
AR - Argentina 104
JP - Giappone 93
NL - Olanda 93
EU - Europa 84
ID - Indonesia 76
IQ - Iraq 76
ZA - Sudafrica 66
ES - Italia 63
TR - Turchia 61
EC - Ecuador 55
IL - Israele 51
PK - Pakistan 48
VE - Venezuela 38
CO - Colombia 36
AU - Australia 33
CH - Svizzera 32
UZ - Uzbekistan 31
SA - Arabia Saudita 28
AT - Austria 26
CL - Cile 26
MA - Marocco 24
PH - Filippine 24
LT - Lituania 23
KR - Corea 18
AE - Emirati Arabi Uniti 17
PT - Portogallo 17
PY - Paraguay 17
RO - Romania 17
MY - Malesia 15
TH - Thailandia 15
BE - Belgio 14
EG - Egitto 14
KE - Kenya 14
TN - Tunisia 14
AZ - Azerbaigian 11
RS - Serbia 11
UY - Uruguay 11
CR - Costa Rica 10
KZ - Kazakistan 10
DZ - Algeria 9
JO - Giordania 9
NP - Nepal 9
NZ - Nuova Zelanda 9
HU - Ungheria 8
SN - Senegal 8
CZ - Repubblica Ceca 7
IR - Iran 7
JM - Giamaica 7
ET - Etiopia 6
KG - Kirghizistan 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
AL - Albania 5
AO - Angola 5
CI - Costa d'Avorio 5
MD - Moldavia 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
GE - Georgia 4
HN - Honduras 4
KW - Kuwait 4
LB - Libano 4
LV - Lettonia 4
OM - Oman 4
PE - Perù 4
PS - Palestinian Territory 4
SV - El Salvador 4
BH - Bahrain 3
BO - Bolivia 3
GT - Guatemala 3
PA - Panama 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BB - Barbados 2
BS - Bahamas 2
BY - Bielorussia 2
GA - Gabon 2
GR - Grecia 2
Totale 46.497
Città #
Dallas 2.956
Southend 2.638
Woodbridge 1.900
Ann Arbor 1.698
Singapore 1.554
San Jose 1.329
Chandler 1.253
Houston 1.159
Ashburn 1.023
Beijing 993
Fairfield 793
San Mateo 790
Hong Kong 696
Dearborn 657
Jacksonville 635
Moscow 465
Seattle 462
Falls Church 455
The Dalles 447
Wilmington 390
Cambridge 384
Wayne 330
Los Angeles 299
Ho Chi Minh City 287
Boardman 263
Dong Ket 255
Stevenage 252
Hefei 223
Portsmouth 219
Lauterbourg 214
Pisa 211
Lawrence 209
Hanoi 192
New York 188
Dublin 182
Chicago 157
Brooklyn 135
Santa Clara 132
Ottawa 123
Beauharnois 121
São Paulo 121
Redwood City 118
Buffalo 100
Warsaw 97
Montréal 91
Guangzhou 87
Helsinki 86
Council Bluffs 84
Rome 81
Tokyo 78
Orem 72
San Diego 71
Munich 70
Old Bridge 69
London 67
Milan 63
Montreal 56
Mexico City 53
Salt Lake City 51
Columbus 49
Tel Aviv 46
Johannesburg 45
Phoenix 42
Stockholm 42
Norwalk 41
Chennai 40
Rio de Janeiro 38
Florence 37
Denver 36
Haiphong 36
Atlanta 35
Baghdad 35
San Francisco 35
Da Nang 33
Manchester 33
Elk Grove Village 31
Toronto 31
Frankfurt am Main 29
Paris 29
Tashkent 29
Poplar 28
Miami 27
Amsterdam 25
Belo Horizonte 25
Curitiba 25
Boston 24
Brasília 23
Turku 23
Cascina 22
Dhaka 22
Mumbai 22
Naples 22
Fremont 21
Lahore 21
New Delhi 20
Tampa 20
Istanbul 19
Nuremberg 19
Porto Alegre 19
Quito 19
Totale 29.402
Nome #
Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction 599
Enabling MSI-Guided Laser Capture Microdissection 430
Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo. 419
3D CMR Mapping of Metabolism by Hyperpolarized 13C-Pyruvate in Ischemia–Reperfusion 417
A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis 402
Surgical Access and Stimulation of the Pig Pudendal Nerve to Restore Bladder Dysfunctions 396
A Dose-Response Elevation in Hepatic Glucose Uptake is Paralleled by Liver Triglyceride Synthesis and Release. 373
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs 354
Acetylation mediates Cx43 reduction caused by electrical stimulation 349
Cardiac adeno-associated virus 9-mediated delivery of nestin-640 prevents myocardial remodeling in a rodent model of post-ischemic heart failure 347
Molecular Advances in Reporter Genes: The Need to Witness the Function of Stem Cells in Failing Heart in Vivo. 330
AAV-Mediated Delivery of VEGF-B Preserves Viability and Cardiac Function Following Myocardial Infarction through a Direct Effect on Cardiomyocyte Survival and Contractility 325
REGIONAL MAPPING OF MYOCARDIAL HIBERNATION PHENOTYPE IN IDIOPATHIC END-STAGE DILATED CARDIOMYOPATHY 323
A partial knockdown of glucose-6-phosphate dehydrogenase impairs cardiac contractile performance and efficiency, in vivo 321
Acute vagal stimulation attenuates cardiac metabolic response to beta-adrenergic stress. 321
An Implantable ZigBee Ready Telemetric Platform For In Vivo Monitoring Of Physiological Parameters 320
A software tool for the real-time in vivo evaluation of neural electrodes' selectivity 310
Adaptation and optimization of an intraneural electrode to interface with the cervical vagus nerve 308
A lightweight learning-based decoding algorithm for intraneural vagus nerve activity classification in pigs 307
Placental stem cells pre-treated with hyaluronan-butyric-retinoic ester to cure infarcted pig hearts: a multimodal study. 300
Gene Therapy for Heart Failure: New Perspectives 294
Neural stimulation hardware for the selective intrafascicular modulation of the vagus nerve 291
Pathogenic role of mitochondrial calcium uniporter upregulation in the failing heart: Ca2+ mishandling or what else? 291
Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure. 291
A fast and accurate learning-based decoding algorithm for the classification of cardiovascular and respiratory challenges using intraneural electrodes in the pig vagus nerve 289
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure 287
Myocardial substrate metabolism in the normal and failing heart 285
Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure 285
Abnormal stress-induced myocardial metabolic changes in patients with dilated cardiomyopathy. 281
Acute NO synthase inhibition profoundly alters myocardial oxidation of free fatty acids and glucose in conscious dogs 281
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. 279
Real time cardiac metabolism assessed with hyperpolarized [1-13C] acetate in a large animal model 278
Acute NO synthase inhibition increases the activities of myocardial glyceraldehyde-3-phosphate-dehydrogenase and malonyl-CoA-decarboxylase in conscious dogs. 277
Q-PINE: A quick to implant peripheral intraneural electrode 276
Multimodal molecular imaging system for pathway-specific reporter gene expression 274
Proteomics-based network analysis characterizes biological processes and pathways activated by preconditioned mesenchymal stem cells in cardiac repair mechanisms 272
Acute and chronic endothelial dysfunction: implications for the development of heart failure. 271
A novel endothelial mechanism that counteracts arteriolar constriction. 269
ACE-inhibitor, modulates myocardial glucose uptake via B2-kinin receptor-mediated cardiac NO production in Langendorff mouse heart. 264
Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart. 263
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 261
Low HDL - high inflammatory markers in heart failure induced by high frequency pacing in minipigs. 258
Mass Spectrometry Imaging as a Tool to Investigate Region Specific Lipid Alterations in Symptomatic Human Carotid Atherosclerotic Plaques 258
Adaptive induction of NF-E2–Related Factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia 254
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5T cardiac MRI in a rat model of myocardial infarction 254
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. 252
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. 252
Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture 252
Acute Vagal Stimulation Attenuates Cardiac Metabolic Response to Beta-adrenergic Stress in Chronically Instrumented Dogs. 248
Modulating Fatty Acid Oxidation in Heart Failure 247
DNP methods for cardiac metabolic imaging with hyperpolarized [1-13C]pyruvate large dose injection in pigs 246
Cardiovascular Molecular Imaging with Hyperpolarized [1-13C] acetate and [1-13C] pyruvate in middle size animal model 245
Intracoronary gene delivery of the cytoprotective factor vascular endothelial growth factor-B167 in canine patients with dilated cardiomyopathy: A short-term feasibility study 243
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure 242
Glucose-6-Phosphate Dehydrogenase Deficiency Increases Myocardial Redox Stress and Moderately Accelerates the Development of Heart Failure 242
LOW HDL-HIGH INFLAMMATORY MARKERS IN HEART FAILURE INDUCED BY HIGH FREQUENCY PACING IN MINIPIGS 242
Altered cardiac metabolic phenotype after prolonged inhibition of NO synthesis in chronically instrumented dogs. 239
Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy 239
Reduced cardiac NO production during pacing-induced heart failure 237
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa. 235
Animal models of dilated cardiomyopathy for translational research. 233
Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. 232
Early mechanical dyssynchrony induced by unipolar left ventricular pacing is unrelated to myocardial flow and metabolism 230
Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs 229
Transthoracic Sensor for Noninvasive Assessment of Left Ventricular Contractility: Validation in A Minipig Model of Chronic Heart Failure. 228
Segmental analysis of cardiac metabolism by hyperpolarized [1-13C] pyruvate: an in-vivo 3D MRI study in pigs 228
Stem cells transduction with ferritin as a reporter gene to track their fate by 1.5 Tesla MRI, in the beating heart. 226
Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. 225
Nestin is a key regulator of cardioprotection and nestin-640 gene therapy rescues infarcted myocardium 224
Post-mortem CMR in a model of sudden death due to myocardial ischemia: validation with connexin-43 223
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats. 223
Chronic inhibition of nitric oxide synthase alters cardiac substrate handling: underestimating changes in metabolism. 223
Pathologic pulse pressure in isolated coronary artery bed augments flow in vivo despite constant ventricular workload 222
Systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance. 221
Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. 221
Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy 221
Nitric oxide-mediated arteriolar dilation after endothelial deformation 220
Reduced left ventricular compliance and mechanical efficiency after prolonged inhibition of NO synthesis in conscious dogs. 220
Diverse protein kinase A-dependent myofilament protein phosphorylation in the background of regional contractile dysfunction in pacing-induced heart failure 220
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure. 219
Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. 218
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. 217
Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. 217
Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. 216
Early detection of acute lung injury uncoupled to hypoxemia in pigs using ultrasound lung comets. 215
In vitro system to study realistic pulsatile flow and stretch signaling in cultured vascular cells 213
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. 213
The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense 213
Adeno-associated virus mediated gene delivery into coronary microvessels of chronically instrumented dogs. 212
Pre-treatment of human mesenchymal stem cells with a chemical inductor of cardiogenesis increases their effects on regional myocardial function in a swine model of myocardial infarction. 212
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. 211
Overview of ventilator-induced lung injury mechanisms 211
Changes in cardiac metabolism produced by acute inhibition of NO synthase can be reversed by a long-acting NO donor 211
Amlodipine releases nitric oxide (NO) from coronary microvessels after pacing induced dilated cardiomyopathy. 211
Cardiac Metabolism in a Pig Model of Ischemia-Reperfusion by Cardiac Magnetic Resonance with Hyperpolarized 13C-Pyruvate 211
Combined PET and Tagging-MRI reveal altered patterns of regional function and metabolism in ventricular dyssynchrony. 209
Short Interfering RNA-Mediated Knockdown Of Glucose-6-Phosphate Dehydrogenase Impairs Cardiac Contractile Performance and Efficiency in Conscious Dogs. 209
Early long‐term L‐T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats 209
Calculation of the protein turnover rate using the number of incorporated 2H atoms and proteomics analysis of a single labeled sample 209
Class I histone deacetylase inhibition for the treatment of sustained atrial fibrillation 206
Totale 26.526
Categoria #
all - tutte 224.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021614 0 0 0 0 0 0 0 0 0 0 0 614
2021/20223.340 170 615 419 278 65 61 315 592 162 323 81 259
2022/20232.877 233 126 48 605 366 469 36 235 481 69 110 99
2023/20241.082 151 66 203 58 65 161 133 31 13 36 42 123
2024/20256.750 79 62 416 237 188 512 1.024 1.924 552 218 770 768
2025/202615.947 780 2.762 1.614 1.691 1.662 965 2.411 779 1.075 1.254 873 81
Totale 46.727